ZENTIVA S.A. preliminary reports for 2020 full year, a turnover of 602 MRON, with an increase of 8% vs previous year, and an operational profit of 61.3 MRON.
Operational profit increased significantly compared with 2019, mainly due to the favorable impact of the legislative environment with the introduction of differentiated clawback and indexation of RX products, as well as due to a better efficiency in the both commercial and production segments.
The financial reports are preliminary and not audited.
Company Zentiva S.A informs about disclosure of preliminary financial report as at 31.12.2020, which can be viewed as follows:
on Company’s website, section “Corporate Governance / Investors”, starting 26.02.2021, 18:30.